Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY Katsunobu Kato Makes Comeback as Health Minister
September 11, 2019
-
BUSINESS Vital-Net Carving Out New Businesses in Regenerative Medicine, Robotics
September 11, 2019
-
REGULATORY MOF Budget Examiner Sounds Alarm on “Protected” Market, Prods Speedy Transformation
September 10, 2019
-
BUSINESS Daiichi Sankyo’s Big-Seller Hopeful DS-8201 Filed in Japan
September 10, 2019
-
BUSINESS To Counter Latuda Patent Cliff, Sumitomo Dainippon Poised to Buy 5 “Vants” Companies from Roivant
September 9, 2019
-
BUSINESS Labor Union Urges MSD Japan to Make Convincing Case on Job Cuts
September 6, 2019
-
REGULATORY In Fight against AMR, Japan Set to Forge Prefectural Networks to Push Proper Antibiotic Use
September 5, 2019
-
BUSINESS Roche/Chugai’s Rozlytrek, AstraZeneca COPD Combos and More Hit Shelves
September 5, 2019
-
BUSINESS Keytruda Boon Aside, MSD Japan Mulls Job Cuts for Sales and Marketing
September 4, 2019
-
BUSINESS Astellas Grabs Global Rights to RIKEN’s aAVC Technology in Oncology
September 3, 2019
-
BUSINESS Astellas Revving Up Digital Transformation Drive, Expands Scope of Data to Derive Values
September 2, 2019
-
TRENDS Sales per Drug Rep Hits Record High in FY2018 as Downsizing Speeds Up
August 30, 2019
-
REGULATORY MHLW Panel Puts a Hold on Possible World’s 1st OK for Ono’s Cancer Cachexia Drug
August 30, 2019
-
ORGANIZATION Japan Doctors’ Group Raps Payer Proposal to Scrap Coverage for Pollen Allergy Drugs
August 29, 2019
-
REGULATORY Rozlytrek, Onpattro and Many More to Join NHI Price List on Sept. 4
August 28, 2019
-
REGULATORY Gene Therapy Collategene Gets 600,000 Yen Price Tag, Peak Sales Put at 1.2 Billion Yen
August 28, 2019
-
REGULATORY Tagrisso to Face 15% Price Cut in November Because It Sold Too Well
August 27, 2019
-
ORGANIZATION Kenporen Proposes Excluding OTC-Like Pollinosis Drugs from Health Coverage, Expecting Annual Savings of 60 Billion Yen
August 26, 2019
-
REGULATORY Japan to Set Up Dedicated Team to Expedite Review of Sakigake-Designated Cell/Gene Therapies
August 23, 2019
-
REGULATORY Tecentriq Wins Japan Nod for SCLC as 1st Checkpoint Drug for This Use
August 23, 2019
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…